Registration

INNOVATIVE FEDERAL STRATEGIES, LLC for ACURX PHARMACEUTICALS, INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Research and clinical trials for the development of antibiotics for infections caused by bacteria listed as priority pathogens.

LobbyistCovered position, as disclosed
ERYNN D HOOK New Chief of Staff/LA/LC/Staff Assistant, Rep. Chris Collins
CARL KIME New —
LETITIA WHITE New Staff Assistant & Appropriations Associate, Rep. Jerry Lewis / House Republican Leadership Staff

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.